Search results
Author(s):
Ryan Wallace
,
Hugh Calkins
Added:
2 years ago
Author(s):
Vincent Probst
,
Stéphanie Chatel
,
Jean-Baptiste Gourraud
,
et al
Added:
3 years ago
Brugada syndrome (BrS) is a clinical entity identified in 1992 by Brugada brothers from a file of patients resuscitated from sudden cardiac death (SCD).1 Of these patients, some had a specific electrocardiogram (ECG) appearance characterised by an incomplete right bundle branch block associated with an ST segment elevation in the right precordial leads. It quickly became apparent that this…
View more
Author(s):
Jorge E Romero
,
Dan L Li
,
Ricardo Avendano
,
et al
Added:
3 years ago
Brugada syndrome (BrS), one of the most common causes of sudden cardiac death (SCD) in normal structural heart individuals, is a young entity in modern medicine. BrS was first characterised in 1992 by Brugada et al. as a distinct syndrome with “right bundle branch block, persistent ST elevation in precordial leads V1 to V2–3 and sudden cardiac death”.1 The true prevalence of BrS is not clearly…
View more
Author(s):
Shohreh Honarbakhsh
,
Rui Providencia
,
Pier D Lambiase
Added:
3 years ago
Brugada syndrome (BrS) remains one of the most common inherited channelopathies associated with an increased risk of sudden cardiac death (SCD), with a worldwide prevalence of approximately 0.05%.1–3 It is accepted that appropriate utilisation of the ICD in high-risk patients with aborted SCD and haemodynamically compromising arrhythmias is life-saving. However, there remains a lack of consensus…
View more
Author(s):
Federico Lombardi
Added:
3 years ago
Atrial fibrillation (AF) is the most common clinical arrhythmia with a relevant socio-economic impact.1–3 Patients with atrial fibrillation are characterised by symptoms such as palpitations and shortness of breath; they have reduced exercise capacity and are subject to a higher risk of thromboembolic events. In spite of a relatively simple diagnosis, management of AF patients is difficult for…
View more
The Role of Cardiac MRI in the Diagnosis and Risk Stratification of Hypertrophic Cardiomyopathy
Author(s):
Ethan J Rowin
,
Martin S Maron
Added:
3 years ago
Article
Author(s):
Roberto Keegan
,
Cynthia Yeung
,
Adrian Baranchuk
Added:
3 years ago
Chagas disease is an important public health problem in Latin America. Almost 25% of the population (approximately 65 million individuals) are at risk of infection and another 6 million people are affected.1 However, migration and globalisation have resulted in the increased presence of Chagas disease worldwide, particularly in the US and Europe.
Chagas disease is caused by a parasite, the…
View more
Added:
1 year ago
In this short interview, conducted at ESC 2022 in Barcelona, Prof David Duncker (Hannover Heart Rhythm Center, Hannover, DE) discusses the relevancy of sudden cardiac death risk, how the recent ESC guidelines protect patients, and considers recommendations for risk stratification.
Discussion topics:
1. Relevancy of sudden cardiac death risk
2. The recently published ESC guidelines
3…
View more
Author(s):
Theodoros A Zografos
Added:
3 years ago
Dear Sir,
I read with great interest the elegant review by Mukherjee and colleagues on prophylactic VT ablation in the latest issue of the journal (AER 6(3)125-8).1 The concept is indeed revolutionary, and should extend the boundaries of interventional electrophysiology. However, such an approach cannot be feasible without rationalising patient selection. Current guidelines’ recommendations,…
View more
Author(s):
Juan Sieira
,
Pedro Brugada
Added:
3 years ago
Brugada syndrome (BS) is an inherited disease characterised by coved-type ST-segment elevation in the right precordial leads (V1–V3) and an increased risk of sudden cardiac death (SCD) in the absence of structural heart disease.1
It typically affects otherwise healthy individuals in their forties.2 SCD is the most dramatic presentation, but many patients are asymptomatic at the time of diagnosis…
View more